174 related articles for article (PubMed ID: 33136534)
41. Chronic Recurrent Vogt-Koyanagi-Harada Disease and Development of 'Sunset Glow Fundus' Predict Worse Retinal Sensitivity.
Abu El-Asrar AM; Al Mudhaiyan T; Al Najashi AA; Hemachandran S; Hariz R; Mousa A; Al-Muammar A
Ocul Immunol Inflamm; 2017 Aug; 25(4):475-485. PubMed ID: 27003480
[TBL] [Abstract][Full Text] [Related]
42. Bilateral peripapillary choroidal neovascular membranes in Vogt-Koyanagi-Harada disease.
Banerjee M; Kumar A; Azad SV; Chawla R
BMJ Case Rep; 2024 Jun; 17(6):. PubMed ID: 38937264
[TBL] [Abstract][Full Text] [Related]
43. SS OCT and OCT-A Findings in Convalescent Inactive Vogt-Koyanagi-Harada Disease.
Ben Aoun S; Ksiaa I; Nefzi D; Khochtali S; Jelliti B; Abroug N; Khairallah M
Ocul Immunol Inflamm; 2024 May; 32(4):407-414. PubMed ID: 37948509
[TBL] [Abstract][Full Text] [Related]
44. Assessment of macular capillary perfusion in patients with inactive Vogt-Koyanagi-Harada disease: an optical coherence tomography angiography study.
Karaca I; Yılmaz SG; Afrashi F; Nalçacı S
Graefes Arch Clin Exp Ophthalmol; 2020 Jun; 258(6):1181-1190. PubMed ID: 32363500
[TBL] [Abstract][Full Text] [Related]
45. Long-term efficacy of dexamethasone intravitreal implant in the treatment of Vogt-Koyanagi-Harada disease relapsing posterior uveitis.
Elhamaky TR
Indian J Ophthalmol; 2022 Jul; 70(7):2465-2470. PubMed ID: 35791135
[TBL] [Abstract][Full Text] [Related]
46. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Hemachandran S; Al-Mezaine HS; Kangave D; Al-Muammar AM
Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
[TBL] [Abstract][Full Text] [Related]
47. [The fundus manifestations and SD-OCT findings of patients with acute Vogt-Koyanagi-Harada disease].
Li B; Ye JJ; Zhang MF; Li DH
Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):436-439. PubMed ID: 28606265
[No Abstract] [Full Text] [Related]
48. Recovery of macular cone photoreceptors in Vogt-Koyanagi-Harada disease.
Nakamura T; Hayashi A; Oiwake T
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):387-394. PubMed ID: 29264653
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of Retinal Pigment Epithelium Layer Change in Vogt-Koyanagi-Harada Disease With Multicontrast Optical Coherence Tomography.
Miura M; Makita S; Azuma S; Yasuno Y; Sugiyama S; Mino T; Yamaguchi T; Agawa T; Iwasaki T; Usui Y; Rao NA; Goto H
Invest Ophthalmol Vis Sci; 2019 Aug; 60(10):3352-3362. PubMed ID: 31917451
[TBL] [Abstract][Full Text] [Related]
50. Therapeutic window of opportunity in the acute uveitic phase of Vogt-Koyanagi-Harada disease: Prevention of late autoimmune complications by early intervention.
Abu El-Asrar AM; Al Rashed FA; AlBloushi AF; Tobaigy MF; Gikandi PW; Herbort CP; Opdenakker G
Acta Ophthalmol; 2023 Mar; 101(2):e236-e245. PubMed ID: 36128841
[TBL] [Abstract][Full Text] [Related]
51. Clinical Outcomes of Patients with Vogt-Koyanagi-Harada Disease Over 12 Years at a Tertiary Center.
Arevalo JF; Lasave AF; Gupta V; Kozak I; Al Harbi MB; Al Rushood AA; Al Dhibi HA
Ocul Immunol Inflamm; 2016 Oct; 24(5):521-9. PubMed ID: 26399962
[TBL] [Abstract][Full Text] [Related]
52. Outcomes of initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease occurred during pregnancy.
Alromaih AZ; Almater AI; Albloushi AF; Alkheraiji NF; Abu El-Asrar AM
Int Ophthalmol; 2023 Jan; 43(1):185-195. PubMed ID: 35945413
[TBL] [Abstract][Full Text] [Related]
53. Optical coherence tomography in the acute and chronic phases of Vogt-Koyanagi-Harada disease.
Parc C; Guenoun JM; Dhote R; Brézin A
Ocul Immunol Inflamm; 2005; 13(2-3):225-7. PubMed ID: 16019683
[TBL] [Abstract][Full Text] [Related]
54. PREDICTIVE ROLE OF SWEPT SOURCE OCT ANGIOGRAPHY IN RELAPSING VOGT-KOYANAGI-HARADA DISEASE.
Interlandi E; Pellegrini F; Papayannis A; Latanza L; Pece A; Pavesio C
Retin Cases Brief Rep; 2023 Jul; 17(4):414-418. PubMed ID: 35880955
[TBL] [Abstract][Full Text] [Related]
55. Relative changes in luminal and stromal areas of choroid determined by binarization of EDI-OCT images in eyes with Vogt-Koyanagi-Harada disease after treatment.
Kawano H; Sonoda S; Yamashita T; Maruko I; Iida T; Sakamoto T
Graefes Arch Clin Exp Ophthalmol; 2016 Mar; 254(3):421-6. PubMed ID: 26847039
[TBL] [Abstract][Full Text] [Related]
56. The spectrum of Vogt-Koyanagi-Harada disease in Iran.
Hedayatfar A; Hosseini SM; Karimi N; Falavarjani KG; Badie N; Zameni M; Soheilian M
Int Ophthalmol; 2018 Apr; 38(2):443-449. PubMed ID: 28260142
[TBL] [Abstract][Full Text] [Related]
57. The Role of Optical Coherence Tomography Angiography in the Diagnosis and Management of Acute Vogt-Koyanagi-Harada Disease.
Aggarwal K; Agarwal A; Mahajan S; Invernizzi A; Mandadi SKR; Singh R; Bansal R; Dogra MR; Gupta V;
Ocul Immunol Inflamm; 2018; 26(1):142-153. PubMed ID: 27440118
[TBL] [Abstract][Full Text] [Related]
58. Enhanced depth imaging optical coherence tomography of the choroid in Vogt-Koyanagi-Harada disease.
Nakayama M; Keino H; Okada AA; Watanabe T; Taki W; Inoue M; Hirakata A
Retina; 2012; 32(10):2061-9. PubMed ID: 23095726
[TBL] [Abstract][Full Text] [Related]
59. Analysis of Three-Dimensional Choroidal Volume with Enhanced Depth Imaging Findings in Patients with Recurrent Vogt-Koyanagi-Harada Disease.
Silpa-Archa S; Ittharat W; Chotcomwongse P; Preble JM; Foster CS
Curr Eye Res; 2021 Jul; 46(7):1010-1017. PubMed ID: 33215546
[No Abstract] [Full Text] [Related]
60. Edema of the photoreceptor layer in Vogt-Koyanagi-Harada disease observed using high-resolution optical coherence tomography.
Lee JE; Park SW; Lee JK; Choi HY; Oum BS; Kim HW
Korean J Ophthalmol; 2009 Jun; 23(2):74-9. PubMed ID: 19568354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
